$268 Million is the total value of Endurant Capital Management LP's 69 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 56.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGN | Buy | ALLERGAN PLC | $17,231,000 | +37.7% | 102,391 | +33.9% | 6.44% | +68.3% |
ABT | Buy | ABBOTT LABS | $16,582,000 | +102.6% | 276,732 | +93.0% | 6.19% | +147.7% |
JNJ | Buy | JOHNSON & JOHNSON | $14,623,000 | +72.1% | 114,111 | +87.7% | 5.46% | +110.3% |
MDT | Buy | MEDTRONIC PLC | $10,839,000 | +15.4% | 135,115 | +16.2% | 4.05% | +41.0% |
BDX | Buy | BECTON DICKINSON & CO | $10,625,000 | +147.3% | 49,030 | +144.3% | 3.97% | +202.3% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $10,592,000 | +24.7% | 387,698 | +13.2% | 3.96% | +52.4% |
UHS | New | UNIVERSAL HLTH SVCS INCcl b | $9,875,000 | – | 83,400 | +100.0% | 3.69% | – |
UNH | Buy | UNITEDHEALTH GROUP INC | $9,717,000 | +14.0% | 45,408 | +17.5% | 3.63% | +39.3% |
ANTM | Buy | ANTHEM INC | $9,690,000 | +91.3% | 44,105 | +95.9% | 3.62% | +133.9% |
MRK | Buy | MERCK & CO INC | $9,407,000 | +57.6% | 172,700 | +62.8% | 3.51% | +92.5% |
DVA | Sell | DAVITA INC | $9,320,000 | -39.9% | 141,336 | -34.2% | 3.48% | -26.6% |
SHPG | Buy | SHIRE PLCsponsored adr | $8,066,000 | +59.0% | 53,996 | +65.1% | 3.01% | +94.4% |
WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $7,871,000 | -39.9% | 120,223 | -33.3% | 2.94% | -26.5% |
SYNH | New | SYNEOS HEALTH INCcl a | $6,830,000 | – | 192,400 | +100.0% | 2.55% | – |
CVS | Buy | CVS HEALTH CORP | $6,477,000 | +67.6% | 104,111 | +95.3% | 2.42% | +104.8% |
MYL | Buy | MYLAN N V | $6,443,000 | +28.1% | 156,487 | +31.6% | 2.41% | +56.6% |
HOLX | Sell | HOLOGIC INC | $6,386,000 | -33.0% | 170,944 | -23.3% | 2.39% | -18.1% |
SBRA | Sell | SABRA HEALTH CARE REIT INC | $5,034,000 | -57.7% | 285,219 | -55.0% | 1.88% | -48.4% |
TMO | Sell | THERMO FISHER SCIENTIFIC INC | $4,915,000 | -40.6% | 23,808 | -45.4% | 1.84% | -27.5% |
LH | Buy | LABORATORY CORP AMER HLDGS | $4,784,000 | +45.8% | 29,575 | +43.7% | 1.79% | +78.2% |
HCA | New | HCA HEALTHCARE INC | $4,346,000 | – | 44,800 | +100.0% | 1.62% | – |
MD | Sell | MEDNAX INC | $4,129,000 | -57.5% | 74,217 | -59.2% | 1.54% | -48.0% |
AET | Sell | AETNA INC NEW | $4,109,000 | -42.2% | 24,312 | -38.3% | 1.54% | -29.4% |
ESRX | Sell | EXPRESS SCRIPTS HLDG CO | $3,785,000 | -32.1% | 54,790 | -26.6% | 1.41% | -17.0% |
GILD | New | GILEAD SCIENCES INC | $3,558,000 | – | 47,200 | +100.0% | 1.33% | – |
CI | Buy | CIGNA CORPORATION | $3,455,000 | +751.0% | 20,600 | +930.0% | 1.29% | +941.1% |
EVHC | Sell | ENVISION HEALTHCARE CORP | $3,158,000 | -53.4% | 82,174 | -58.1% | 1.18% | -43.1% |
CELG | Sell | CELGENE CORP | $2,855,000 | -27.6% | 32,000 | -15.3% | 1.07% | -11.6% |
TVTY | Sell | TIVITY HEALTH INC | $2,411,000 | -74.5% | 60,819 | -76.5% | 0.90% | -68.8% |
PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $2,335,000 | -55.4% | 71,500 | -33.6% | 0.87% | -45.5% |
WMGI | Sell | WRIGHT MED GROUP N V | $2,243,000 | -66.9% | 113,072 | -63.0% | 0.84% | -59.5% |
PTI | Sell | PROTEOSTASIS THERAPEUTICS IN | $2,242,000 | -20.7% | 472,012 | -2.7% | 0.84% | -3.0% |
BAX | Sell | BAXTER INTL INC | $2,169,000 | -33.2% | 33,349 | -33.6% | 0.81% | -18.4% |
HRC | Sell | HILL ROM HLDGS INC | $2,123,000 | -62.0% | 24,400 | -63.1% | 0.79% | -53.5% |
DHR | Sell | DANAHER CORP DEL | $2,082,000 | -80.2% | 21,265 | -81.3% | 0.78% | -75.9% |
OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $2,056,000 | -74.2% | 165,169 | -71.0% | 0.77% | -68.5% |
FOLD | Sell | AMICUS THERAPEUTICS INC | $1,910,000 | -35.7% | 127,000 | -38.5% | 0.71% | -21.5% |
MASI | New | MASIMO CORP | $1,838,000 | – | 20,900 | +100.0% | 0.69% | – |
CLVS | Sell | CLOVIS ONCOLOGY INC | $1,748,000 | -62.0% | 33,100 | -51.1% | 0.65% | -53.6% |
PBYI | Sell | PUMA BIOTECHNOLOGY INC | $1,681,000 | -43.1% | 24,700 | -17.4% | 0.63% | -30.5% |
MCK | Sell | MCKESSON CORP | $1,623,000 | -85.6% | 11,523 | -84.0% | 0.61% | -82.4% |
INCY | Buy | INCYTE CORP | $1,618,000 | +130.2% | 19,420 | +161.7% | 0.60% | +180.9% |
FATE | Sell | FATE THERAPEUTICS INC | $1,516,000 | -55.4% | 155,344 | -72.1% | 0.57% | -45.6% |
ENDOLOGIX INCnote 2.250%12/1 | $1,498,000 | +1.5% | 1,541,000 | 0.0% | 0.56% | +24.2% | ||
PPH | New | VANECK VECTORS ETF TRpharmaceutical | $1,449,000 | – | 25,500 | +100.0% | 0.54% | – |
PKI | Buy | PERKINELMER INC | $1,442,000 | +109.6% | 19,041 | +102.5% | 0.54% | +156.7% |
CAH | Sell | CARDINAL HEALTH INC | $1,413,000 | -77.3% | 22,542 | -77.9% | 0.53% | -72.3% |
VRX | New | VALEANT PHARMACEUTICALS INTL | $1,356,000 | – | 85,200 | +100.0% | 0.51% | – |
A | New | AGILENT TECHNOLOGIES INC | $1,338,000 | – | 20,000 | +100.0% | 0.50% | – |
DGX | New | QUEST DIAGNOSTICS INC | $1,304,000 | – | 13,000 | +100.0% | 0.49% | – |
ARRY | Buy | ARRAY BIOPHARMA INC | $1,165,000 | +79.8% | 71,400 | +41.1% | 0.44% | +119.7% |
OCUL | New | OCULAR THERAPEUTIX INC | $1,162,000 | – | 178,461 | +100.0% | 0.43% | – |
ICLR | New | ICON PLC | $992,000 | – | 8,400 | +100.0% | 0.37% | – |
BLCM | New | BELLICUM PHARMACEUTICALS INC | $947,000 | – | 144,300 | +100.0% | 0.35% | – |
NVRO | Sell | NEVRO CORP | $927,000 | -50.2% | 10,701 | -60.3% | 0.35% | -39.2% |
TFX | New | TELEFLEX INC | $918,000 | – | 3,600 | +100.0% | 0.34% | – |
JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $770,000 | +15.4% | 5,100 | +3.0% | 0.29% | +41.2% |
REGN | Sell | REGENERON PHARMACEUTICALS | $758,000 | -64.0% | 2,200 | -60.7% | 0.28% | -56.0% |
RDUS | Sell | RADIUS HEALTH INC | $686,000 | -47.8% | 19,100 | -53.9% | 0.26% | -36.3% |
XRAY | New | DENTSPLY SIRONA INC | $664,000 | – | 13,200 | +100.0% | 0.25% | – |
QGEN | New | QIAGEN NV | $662,000 | – | 20,500 | +100.0% | 0.25% | – |
ZGNX | Sell | ZOGENIX INC | $653,000 | -18.5% | 16,300 | -18.5% | 0.24% | -0.4% |
ALRN | Sell | AILERON THERAPEUTICS INC | $615,000 | -32.1% | 75,697 | -12.0% | 0.23% | -17.0% |
MDCO | Sell | MEDICINES CO | $560,000 | -50.3% | 17,000 | -58.7% | 0.21% | -39.2% |
VKTX | New | VIKING THERAPEUTICS INC | $520,000 | – | 119,100 | +100.0% | 0.19% | – |
RETA | New | REATA PHARMACEUTICALS INCcl a | $513,000 | – | 25,000 | +100.0% | 0.19% | – |
AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $406,000 | – | 55,700 | +100.0% | 0.15% | – |
AKTX | Sell | AKARI THERAPEUTICS PLCsponsored adr | $359,000 | -58.8% | 197,497 | -1.8% | 0.13% | -49.6% |
ANAB | Sell | ANAPTYSBIO INC | $326,000 | -66.6% | 3,130 | -67.7% | 0.12% | -59.2% |
DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -18,837 | -100.0% | -0.05% | – |
BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -10,300 | -100.0% | -0.08% | – |
SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -31,100 | -100.0% | -0.11% | – |
APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -17,600 | -100.0% | -0.12% | – |
ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -9,500 | -100.0% | -0.13% | – |
OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -139,100 | -100.0% | -0.17% | – |
INSM | Exit | INSMED INC | $0 | – | -22,910 | -100.0% | -0.22% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -10,100 | -100.0% | -0.28% | – |
VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -32,500 | -100.0% | -0.30% | – |
IMGN | Exit | IMMUNOGEN INC | $0 | – | -210,800 | -100.0% | -0.41% | – |
EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -12,216 | -100.0% | -0.42% | – |
TCMD | Exit | TACTILE SYS TECHNOLOGY INC | $0 | – | -50,900 | -100.0% | -0.45% | – |
ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -37,828 | -100.0% | -0.46% | – |
ARA | Exit | AMERICAN RENAL ASSOCIATES HO | $0 | – | -89,129 | -100.0% | -0.47% | – |
HUM | Exit | HUMANA INC | $0 | – | -6,800 | -100.0% | -0.52% | – |
MEDP | Exit | MEDPACE HLDGS INC | $0 | – | -63,100 | -100.0% | -0.70% | – |
AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -45,366 | -100.0% | -0.83% | – |
SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -48,800 | -100.0% | -0.83% | – |
SYK | Exit | STRYKER CORP | $0 | – | -17,867 | -100.0% | -0.85% | – |
ENTL | Exit | ENTELLUS MED INC | $0 | – | -189,268 | -100.0% | -1.41% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -15,399 | -100.0% | -1.50% | – |
INCR | Exit | INC RESH HLDGS INCcl a | $0 | – | -112,900 | -100.0% | -1.50% | – |
ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -55,240 | -100.0% | -1.55% | – |
BBH | Exit | VANECK VECTORS ETF TRbiotech etf | $0 | – | -49,899 | -100.0% | -1.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
MCKESSON CORP | 27 | Q1 2023 | 4.4% |
CENCORA INC | 26 | Q3 2023 | 5.9% |
HOLOGIC INC | 24 | Q3 2023 | 7.5% |
JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-04-10 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
SC 13D/A | 2023-09-08 |
13F-HR | 2023-08-14 |
3/A | 2023-05-24 |
13F-HR | 2023-05-15 |
3 | 2023-05-15 |
SC 13D | 2023-05-15 |
SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.